Assignee profile

Ascentage Pharma Suzhou

Coverage of patents, compounds and activity records linked to this assignee.

1 patents10 compounds10 activity records
Summary
AssigneeAscentage Pharma Suzhou
Filing years2025
Patents1
Compounds10
Activity records10
Patent families1
Targets1
Assay familiesdegradation
Activity metricsDC50
Overview

Target distribution and active-compound trend

Target distribution

10 activity records

1 targets

Active compounds by publication year

Distinct compounds linked to assignee patent publications

05102025
Activity compounds and values

Activity records

10 records
Structure
Control
Value
ConcentrationTime
Record IDCompoundAssayDetails
2D structure for PGDB_C009158
DC50-=2.95nM-—BCL6-OCI-LY1WO2025242013A1PGDB_A009718PGDB_C009158PGDB_AS001697View
2D structure for PGDB_C009159
DC50-=937nM-—BCL6-OCI-LY1WO2025242013A1PGDB_A009900PGDB_C009159PGDB_AS001697View
2D structure for PGDB_C009161
DC50-=267nM-—BCL6-OCI-LY1WO2025242013A1PGDB_A012735PGDB_C009161PGDB_AS001697View
2D structure for PGDB_C009164
DC50-=493nM-—BCL6-OCI-LY1WO2025242013A1PGDB_A025515PGDB_C009164PGDB_AS001697View
2D structure for PGDB_C009167
DC50-=78nM-—BCL6-OCI-LY1WO2025242013A1PGDB_A026997PGDB_C009167PGDB_AS001697View
2D structure for PGDB_C009163
DC50-=91nM-—BCL6-OCI-LY1WO2025242013A1PGDB_A037820PGDB_C009163PGDB_AS001697View
2D structure for PGDB_C009166
DC50-=621nM-—BCL6-OCI-LY1WO2025242013A1PGDB_A044616PGDB_C009166PGDB_AS001697View
2D structure for PGDB_C009165
DC50-=450nM-—BCL6-OCI-LY1WO2025242013A1PGDB_A058686PGDB_C009165PGDB_AS001697View
2D structure for PGDB_C009162
DC50-=321nM-—BCL6-OCI-LY1WO2025242013A1PGDB_A069693PGDB_C009162PGDB_AS001697View
2D structure for PGDB_C009160
DC50-=160nM-—BCL6-OCI-LY1WO2025242013A1PGDB_A075292PGDB_C009160PGDB_AS001697View
Page 1 of 1 · 10 records